Skip to main content
SpringerLink
Log in

Pharmacokinetic Characterisation of Transdermal Delivery Systems

  • Review Article
  • Drug Delivery Systems
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

The key aspects of the pharmacokinetics of transdermal delivery systems including time lag, steady-state plasma levels and decline phase are illustrated in this review. The 7 currently marketed transdermal systems [nitroglycerin (glyceryl trinitrate), estradiol, clonidine, fentanyl, nicotine, scopolamine (hyoscine) and estradiol/norethisterone acetate] are discussed, as are systems in development.

Single-dose absolute bioavailability studies characterise the period of onset, the steady-state plateau and the declining phase, and typify transdermal delivery. More complex temporal profiles result from interactions with enhancers or removal of the system before steady-state conditions are achieved. Clinically these systems are used to achieve multiple peak serum estradiol concentrations after application of transdermal estradiol, and an initial peak systemic concentration of testosterone after application of transdermal testosterone. Multiple-dose, dose proportionality and skin site bioequivalence studies are needed for the full pharmacokinetic characterisation of a transdermal delivery system.

The relationship of system design to variability is discussed. Although the data are limited, population factors, cutaneous metabolism and tolerance all appear to influence the disposition of drugs administered transdermally. For example, the route of delivery influences which nitroglycerin metabolite predominates. Futhermore, as a result of tolerance to nitrates, a transdermal delivery system must be removed for 8 to 12 hours for optimal effect.

Therefore, transdermal delivery systems, designed on the basis of pharmacokinetic principles and concentration-effect relationships, have the potential to provide optimal therapy for the treatment of some conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abelin Th, Ehrsam R, Buhler-Reichert Imhof PR, Muller Ph, Thommen A, et al. Effectiveness of a transdermal nicotine system in smoking cessation studies. Methods and Findings in Experimental and Clinical Pharmacology 11: 205–214, 1989

    PubMed  CAS  Google Scholar 

  • Ahmed SR, Boucher AE, Manni A, Santen RJ, Bartholomew M, et al. Transdermal testosterone therapy in the treatment of male hypogonadism. Journal of Clinical Endocrinology and Metabolism 66: 546–551, 1988

    Article  PubMed  CAS  Google Scholar 

  • Arndts D, Arndts K. Pharmacokinetics and pharmacodynamics of transdermally administered clonidine. European Journal of Clinical Pharmacology 26: 79–85, 1984

    Article  PubMed  CAS  Google Scholar 

  • Benowitz NL, Chan K, Denaro CP, Jacob III P. Stable isotope method for studying transdermal drug absorption: the nicotine patch. Clinical Pharmacology and Therapeutics 50: 286–293, 1991

    Article  PubMed  CAS  Google Scholar 

  • Berner B. Pharmacokinetics of skin penetration. In Kydonieus & Berner (Eds) The transdermal delivery of drugs, Vol. II, pp. 133–148, CRC Press, Boca Raton, 1987

    Google Scholar 

  • Berner B, Cooper ER. Asymptotic solutions for nonsteady-state diffusion through oil-water multilaminates. Journal of Membrane Science 14: 139–145, 1983

    Article  CAS  Google Scholar 

  • Berner B, Dinh S. Fundamental concepts in controlled release. In Kydonieus (Ed.) Treatise on controlled drug delivery, pp. 1–35, Marcel Dekker Inc., New York, 1992

    Google Scholar 

  • Berner B, Mazzenga GC, Gargiulo PM, Steffens R. A transdermal nicotine system: feasibility studies. Journal of Controlled Release 20: 13–20, 1992

    Article  CAS  Google Scholar 

  • Berner B, Mazzenga GC, Otte JH, Steffens RJ, Juang RH, et al. Ethanol-water mutually enhanced transdermal therapeutic system II: skin permeation of ethanol and nitroglycerin. Journal of Pharmaceutical Sciences 78: 402–407, 1989

    Article  PubMed  CAS  Google Scholar 

  • Branche Jr GC, Batts JM, Dowdy VM, Field LS, Francis CK. Improving compliance in an inner-city hypertensive patient population. American Journal of Medicine 91 (Suppl. 1A): 37S–41S, 1991

    Article  PubMed  Google Scholar 

  • Brodde OE, Daul A. Alpha and beta-adrenoreceptor changes in patients on maintenance hemodialysis. Contributions to Nephrology 41: 99–107, 1984

    PubMed  CAS  Google Scholar 

  • Castello-Branco C, Martinez de Osaba MJ, Poar F, Gonzalez-Merlo J. The effect of hormone replacement therapy on post-menopausal bone loss. European Journal of Obstetrics, Gynecology and Reproductive Biology 44: 131–136, 1992

    Article  Google Scholar 

  • Chan KKH, Ross HD, Berner B, Piraino AJ. Pharmacokinetics of a single transdermal dose of nicotine in healthy smokers. Journal of Controlled Release 14: 145–151, 1990

    Article  CAS  Google Scholar 

  • Clissold SP, Heel RC. Transdermal hyoscine (scopolamine): a preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs 29: 189–207, 1985

    Article  PubMed  CAS  Google Scholar 

  • Comfort AR, Dinh S, Otte J, Shevchuk I, Berner B. Design of an enhanced transdermal system. Biomaterials 11: 729–733, 1990

    Article  PubMed  CAS  Google Scholar 

  • Cowan JC. Avoiding nitrate tolerance. British Journal of Clinical Pharmacology 34: 96–101, 1992

    Article  PubMed  CAS  Google Scholar 

  • Crank J, Park GS. Methods of measurement. In Crank & Park (Eds) Diffusion in polymers, pp. 1–39, Academic Press, London, 1968

    Google Scholar 

  • Cussler EL. Diffusion: mass transfer in fluid systems, p. 24, Cambridge University Press, New York, 1984

    Google Scholar 

  • Davis GF, Winter L. Cumulative irritation study of placebo transdermal estrogen patches. Current Therapeutic Research 42: 712–719, 1987

    Google Scholar 

  • de Millano PA, Koster RW, Bar FW, Janssen J, de Cock C, et al. Long-term efficacy of continuous and intermittent use of transdermal nitroglycerin in stable angina pectoris. American Journal of Cardiology 68: 857–862, 1991

    Article  Google Scholar 

  • Duthie DJR, Rowbotham DJ, Wyld R, Henderson PD, Nimmo WS. Plasma fentanyl concentrations during transdermal delivery of fentanyl to surgical patients. British Journal of Anaesthesia 60: 614–618, 1988

    Article  PubMed  CAS  Google Scholar 

  • Findlay JC, Place VA, Snyder PJ. Transdermal delivery of testosterone. Journal of Clinical Endocrinology and Metabolism 64: 266–268, 1987

    Article  PubMed  CAS  Google Scholar 

  • Fox KM, Dargie HJ, Deanfield J, Maseri A. Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. British Heart Journal 66: 131–135, 1991

    Article  Google Scholar 

  • Fung HL. Pharmacokinetics and pharmacodynamics of organic nitrates. American Journal of Cardiology 60: 4H–9H, 1987

    Article  PubMed  CAS  Google Scholar 

  • Good WR, Powers MS, Campbell P, Schenkel L. Anew transdermal delivery system for estradiol. Journal of Controlled Release 2: 89–97, 1985

    Article  CAS  Google Scholar 

  • Gourlay GK, Kowalski SR, Plummer JL, Cherry DA, Szekely SM, et al. The efficacy of transdermal fentanyl in the treatment of post-operative pain: a double-blind comparison of fentanyl and placebo systems. Pain 40: 21–28, 1990

    Article  PubMed  CAS  Google Scholar 

  • Hogan JC, Lewis MJ, Henderson AH. Chronic administration of N-acetylcysteine fails to prevent nitrate tolerance in patients with stable angina pectoris. British Journal of Clinical Pharmacology 30: 573–577, 1990

    Article  PubMed  CAS  Google Scholar 

  • Hulter HN, Licht JH, Flacki LP, Singh S. Clinical efficacy and pharmacokinetics of clonidine in hemodialysis and renal insufficiency. Journal of Laboratory and Clinical Medicine 94: 223–231, 1979

    PubMed  CAS  Google Scholar 

  • Katz RJ, Levy WS, Buff L, Wasserman A. Prevention of nitrate tolerance with angiotensin converting enzyme inhibitors. Circulation 83: 1271–1277, 1991

    Article  PubMed  CAS  Google Scholar 

  • Kikoji T, Gumbleton M, Higo N, Guy RH, Benet LZ. Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro. Pharmaceutical Research 8: 1231–1237, 1991

    Article  Google Scholar 

  • Klein C, Morton N, Kelley S, Metz S. Transdermal clonidine therapy in elderly mild hypertensives: effects on blood pressure, plasma norepinephrine and fasting plasma glucose. Journal of Hypertension 3: S81–S84, 1985

    Article  PubMed  CAS  Google Scholar 

  • Kochak GM, Berner B, DeWitte W, Leal M, Sambol NC. Variational analysis of the transdermal delivery rate from two prototypical ethanol-water nitroglycerin TTS devices and Transderm-Nitro 10 in the normal population. Journal of Pharmacokinetics and Biopharmaceutics 20: 443–459, 1992

    PubMed  CAS  Google Scholar 

  • Levy WS, Katz RJ, Wasserman AG. Methionine restores the venodilative response to nitroglycerin after the development of tolerance. Journal of the American College of Cardiology 17: 474–479, 1991

    Article  PubMed  CAS  Google Scholar 

  • Liu P, Higuchi WI, Song W, Kurihara-Bergstrom T, Good WR. Quantitative evaluation of ethanol effects on diffusion and metabolism of β-estradiol in hairless mouse skin. Pharmaceutical Research 8: 865–872, 1991

    Article  PubMed  CAS  Google Scholar 

  • Loo JCK, Riegelman S. New method for calculating the intrinsic absorption rate of drugs. Journal of Pharmaceutical Sciences 57: 918–928, 1968

    Article  PubMed  CAS  Google Scholar 

  • Loper KA, Ready LB, Dorman BH. Prophylactic transdermal scopolamine patches reduce nausea in post-operative patients receiving epidermal morphine. Anesthesia and Analgesia 68: 144–146, 1989

    Article  PubMed  CAS  Google Scholar 

  • Lowenthal DT, Matzek KM, MacGregor TR. Clinical pharmacokinetics of clonidine. Clinical Pharmacokinetics 14: 287–310, 1988

    Article  PubMed  CAS  Google Scholar 

  • Lowenthal DT, Saris S, Paran E, Cristal N, Shark K, et al. Efficacy of clonidine as transdermal therapeutic system: the international clinical experience. American Heart Journal 112: 893–900, 1986

    Article  PubMed  CAS  Google Scholar 

  • Maibach H. Clonidine: irritant and allergic contact dermatitis assays. Contact Dermatitis 12: 192–195, 1985

    Article  PubMed  CAS  Google Scholar 

  • MacGregor TR, Matzek KM, Keirns JJ, van Wayjen RGA, van den Ende A, et al. Pharmacokinetics of transdermally delivered clonidine. Clinical Pharmacology and Therapeutics 38: 278–284, 1985

    Article  PubMed  CAS  Google Scholar 

  • Mazer NA, Heiber WE, Moellmer JF, Meikle AW, Stringham JD, et al. Enhanced transdermal delivery of testosterone: a new physiological approach for androgen replacement in hypogonadal men. Journal of Controlled Release 19: 347–362, 1992

    Article  CAS  Google Scholar 

  • Meikle AW, Mazer NA, Moellmer JF, Stringham JD, Tolman KG, et al. Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 74: 623–628, 1992

    Article  PubMed  CAS  Google Scholar 

  • Nakashima E, Noonan PK, Benet LZ. Transdermal bioavailability and first-pass skin metabolism: a preliminary evaluation with nitroglycerin. Journal of Pharmacokinetics and Biopharmaceutics 15: 423–437, 1987

    PubMed  CAS  Google Scholar 

  • Needleman P, Jashik B, Johnson EM. Sulfhydryl requirement for relaxation of vascular smooth muscle. Journal of Pharmacology and Experimental Therapeutics 187: 324–331, 1973

    PubMed  CAS  Google Scholar 

  • Parker JD, Farrell B, Fenton T, Cohanim M, Parker JO. Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin. Circulation 84: 2338–2345, 1991

    Google Scholar 

  • Patel DC, Chang Y. Penetration enhancement with binary system of oleic acid, oleins, and oleyl alcohol with lower alcohols, US Patent No. 4,863,970, 1989

  • Physician’s Desk Reference, 46th ed., pp. 866–868, 1133–1138, 2386–2388, Medical Economics Data, New Jersey, 1992

  • Ross HD, Chan KKH, Piraino AJ, John VA. Pharmacokinetics of multiple daily transdermal doses of nicotine in healthy smokers. Pharmaceutical Research 8: 385–388, 1991

    Article  PubMed  CAS  Google Scholar 

  • Santus GC, Watari W, Hinz RS, Benet LZ, Guy RH. Cutaneous metabolism of transdermally delivered nitroglycerin in vitro. In Shroot & Schaefer (Eds) Skin pharmacokinetics, Vol. II, pp. 240–244, Karger, Basel, 1987

    Google Scholar 

  • Schaer DH, Buff LA, Katz RJ. Sustained antianginal effect of transdermal nitroglycerin patches using an overnight 10-hour nitrate-free interval. American Journal of Cardiology 61: 46–50, 1988

    Article  PubMed  CAS  Google Scholar 

  • Schenkel L. Development of a combined norethisterone acetate/estradiol TTS. In Whitehead & Schenkel (Eds) Transdermal hormone replacement: long-term effects, pp. 59–65, Parthenon Publications, Carnforth, 1990

    Google Scholar 

  • Schenkel L, Muller P, Pethica D. Dermal and transdermal delivery — new insights and perspectives. In Gurny & Teubner (Eds) Second International Symposium of the International Association for Pharmaceutical Technology, 1992

    Google Scholar 

  • Scheuplein RJ, Blank IH. Permeability of the skin. Physiological Reviews 51: 702–747, 1971

    PubMed  CAS  Google Scholar 

  • Shaw J. Transdermal therapeutic systems. In Brandau & Lippold (Eds) Dermal and transdermal absorption, pp. 171–187, Wissenschaftliche Verlagsgesellschaft mBH, Stuttgart, 1982

    Google Scholar 

  • Shaw JE, Crammer MP, Gale R. Rate-controlled transdermal therapy using polymeric membranes. In Kydonieus & Berner (Eds) Transdermal delivery of drugs, Vol. I, pp. 101–116, CRC Press, Boca Raton, Florida 1987

    Google Scholar 

  • Steffens RJ, Hayes MJ, Powell M, Berner B, Morgan J, et al. The cutaneous metabolism of nitroglycerin. Proceedings of the International Symposium of Controlled Release Biomaterial 19: 236–237, 1992

    Google Scholar 

  • Steingold KA, Laufer L, Chetkowski RJ, DeFazio JD, Matt DW, et al. Treatment of hot flushes with transdermal estradiol administration. Journal of Clinical Endocrinology and Metabolism 61: 627–632, 1985

    Article  PubMed  CAS  Google Scholar 

  • Toon S, Hopkins KJ, Aarons L, Rowland M. Rate and extent of absorption of clonidine from a transdermal therapeutic system. Journal of Pharmacy and Pharmacology 41: 17–21, 1989

    Article  PubMed  CAS  Google Scholar 

  • Torfgard KE, Ahlner J, Axelsson KL, Norlander B, Bertler A. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate and 1,3-glyceryl dinitrate in tolerant and nontolerant rats. Drug Metabolism and Disposition 20: 553–558, 1992

    PubMed  CAS  Google Scholar 

  • Transdermal Nitroglycerin Cooperative Study. Acute and chronic antianginal efficacy of continuous twenty-four hour application of transdermal nitroglycerin. American Journal of Cardiology 68: 1263–1273, 1991

    Article  Google Scholar 

  • Vaughn DP, Dennis M. Mathematical basis of point-areas deconvolution method for determining in vivo input functions. Journal of Pharmaceutical Sciences 67: 663–665, 1978

    Article  Google Scholar 

  • Wagner JG, Nelson E. Kinetic analysis of blood levels and urinary excretion in the absorption phase after single dose of drug. Journal of Pharmaceutical Sciences 53: 1392–1403, 1964

    Article  PubMed  CAS  Google Scholar 

  • Wester RC, Maibach HI. Percutaneous absorption of drugs. Clinical Pharmacokinetics 23: 253–266, 1992

    Article  PubMed  CAS  Google Scholar 

  • Wester R, Noonan PK, Smeach S, Kosubud L. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimate of percutaneous first-pass metabolism. Journal of Pharmaceutical Sciences 72: 745–748, 1983

    Article  PubMed  CAS  Google Scholar 

  • Whitehead MI, Padwick ML, Endacott J, Pryse-Davies J. Treatment of post-menopausal women with transdermal delivery of estradiol. American Journal of Obstetrics and Gynecology 152: 1079–1084, 1985

    PubMed  CAS  Google Scholar 

  • Wiegand A, Bauer K-H, Bohn R, Trenk D, Jahnchen E. Pharmacodynamic and pharmacokinetic evaluation of a new transdermal delivery system with a time-dependent release of glyceryl trinitrate. Journal of Clinical Pharmacology 32: 77–84, 1992

    PubMed  CAS  Google Scholar 

  • Zaffaroni A. Industrial development of transdermal therapeutic systems. In Brandau & Lippold (Eds) Dermal and transdermal absorption, pp. 188–201, Wissenschaftliche Verlagsgesellschaft mBH, Stuttgart, 1982

    Google Scholar 

  • Zeller FP, Klamearus K. Controversies in the use of transdermal nitroglycerin systems. Clinical Pharmacology 6: 605–616, 1987

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ciba-Geigy Corporation, 444 Saw Mill River Road, Ardsley, New York, 10502-2699, USA

    Bret Berner & Vivian A. John

Authors
  1. Bret Berner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vivian A. John
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berner, B., John, V.A. Pharmacokinetic Characterisation of Transdermal Delivery Systems. Clin. Pharmacokinet. 26, 121–134 (1994). https://doi.org/10.2165/00003088-199426020-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199426020-00005

Keywords

Search

Navigation